Etodolac: profile and news

Shire plc: Strong 2005 Performance Supports Positive Outlook  Feb 23, 2006
EQUETRO(TM) (carbamazepine extended-release capsules) FOSRENOL(R) (lanthanum carbonate) GA-GCB(R) (gene-activated) LODINE (R) (etodolac) MESAVANCE(TM ... - PR Newswire (press release),

Tylenol effective for arthritis pain  Feb 7, 2006
The following prescription drugs should never be taken together with acetaminophen: diclofenac, diflunisal, etodolac, fenoprofen, floctafenine, flubiprofen ... - Auburn Citizen,

Tylenol effective for arthritis pain  Feb 7, 2006
The following prescription drugs should never be taken together with acetaminophen: diclofenac, diflunisal, etodolac, fenoprofen, floctafenine, flubiprofen ... - Auburn Citizen,

Visiting Veterinarian: Arthritis pain relief for Rover  Dec 7, 2005
...ideal NSAID would inhibit COX-2 and spare COX-1. Prescription NSAIDs for dogs include carprofen (Rimadyl), deracoxib (Deramaxx), etodolac (Etogesic), meloxicam ... - Martha's Vineyard Times,

Sleep deprivation makes driving dangerous  Sep 18, 2005
..."Mary, you have two choices: Either change your medication, or die in a pool of your own blood.". Then he prescribed Lodine (etodolac). ... - Houston Chronicle,

Even if you wash hands, restroom germs still lurk  Sep 19, 2005
...tablets a day, he said: "Mary, you have two choices: Either change your medication, or die in a pool of your own blood." Then he prescribed Lodine (etodolac). ... - Charlotte Observer,

FDA Safety Labeling Changes: Requip, Lodine, Zestril  Aug 24, 2005
...for the treatment of moderate to severe restless legs syndrome is associated with risks of somnolence, syncope, and hypotension; use of etodolac is associated ... - Medscape (subscription)

Vital Signs Older pain drugs set for comeback  Aug 23, 2005
Mobic, from Boehringer Ingelheim and Abbott Laboratories (ABT: news, chart, profile) , along with generic diclofinac, sold as Voltaren, and etodolac, sold as ... - MarketWatch

CHMP review of safety of non-selective NSAIDs, EMEA  06 Aug 2005
...this review? Diclofenac, Etodolac, Ibuprofen, Indomethacin, Ketoprofen, Meloxicam, Nabumetone, Naproxen and Nimesulide. As part ... - I-Newswire.com (press release)

EMEA on the Cardiovascular Safety of Non-Selective NSAIDs  Aug 2, 2005
1. Non-selective NSAIDs included in this review (whether prescription or non-prescription products) are: Diclofenac, Etodolac, Ibuprofen, Indomethacin ... - PharmaLive.com (press release)

Veterinary Topics: New side to a drug of choice  Jun 6, 2005
Blikslager said. Two drugs they have tested, EtoGesic (etodolac) and Deramaxx (deracoxib), had significant drawbacks. EtoGesic did ... - Thoroughbred Times,

Salmedix, Inc. Presents Preclinical Data for Treanda and Other ...  Apr 14, 2005
Other meeting presentations include reports on preclinical studies with SDX-101 (R-etodolac), a "first-in-class", non-cytotoxic oral drug being investigated by ... - Business Wire

Another painkiller, Bextra, ordered pulled  Apr 8, 2005
Naprosyn (naproxen), Relafen (nabumetone), Motrin (ibuprofen), Clinoril (sulindac), Trilisate (magnesium trisalicylate), Lodine (etodolac) and Indocin ... - San Diego Union Tribune

Risk for Heart Attacks with Different NSAIDs  Apr 4, 2005
...relieve pain. Examples of NSAIDs include aspirin, etodolac (Lodine), ibuprofen (Advil or Motrin), and naproxen (Aleve). NSAIDs can ... - Annals of Internal Medicine

Caution urged on alternative painkillers  Mar 8, 2005
Researchers and public health advocates generally mention five drugs as potentially in the COX-2 inhibitor class: Mobic, diclofenac, etodolac, nabumetone and ... - Newsday,

Other painkillers under scrutiny as use increases  Feb 28, 2005
Researchers and public health advocates generally mention five drugs as potentially in the Cox-2 inhibitor class: Mobic, diclofenac, etodolac and nabume tone ... - Baltimore Sun

What you should know about COX-2 inhibitors  Mar 9, 2005
The diclofenac you take is among the traditional NSAIDs that appear to be less harsh on the stomach. Others are ibuprofen, meloxicam, nabumetone and etodolac. ... - Pioneer Press,

For Pain Management, Doctors Prescribe Caution  Feb 21, 2005
...inflammatories that are somewhat gentler on the stomach than ibuprofen or naproxen - for example, nabumetone (marketed as Relafen) or etodolac (Lodine) - along ... - Spartanburg Herald Journal (subscription),

Pet Prescriptions: Online VS Vet  Feb 20, 2005
...vet. The cheapest we found online was $7.99. Etodolac, a pain reliever for arthritis, cost at least $2 per pill at the vet. But ... - WKOW,

ACE-inhibitors

Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors.

Antacids

The concomitant administration of antacids has no apparent effect on the extent of absorption of Lodine. However, antacids can decrease the peak concentration reached by 15% to 20% but have no detectable effect on the time-to-peak.

Aspirin

When Lodine is administered with aspirin, its protein binding is reduced, although the clearance of free etodolac is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of Lodine and aspirin is not generally recommended because of the potential of increased adverse effects.

Cyclosporine, Digoxin, Methotrexate

Lodine, like other NSAIDs, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine, digoxin, methotrexate, and increased toxicity. Nephrotoxicity associated with cyclosporine may also be enhanced. Patients receiving these drugs who are given Lodine, or any other NSAID, and particularly those patients with altered renal function, should be observed for the development of the specific toxicities of these drugs.

Diuretics

Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or hydrochlorothiazide. Nevertheless, clinical studies, as well as postmarketing observations have shown that Lodine can reduce the natriuretic effect of furosemide and thiazides in some patients. This response has been attributed to inhibition of renal prostaglandin synthesis. During concomitant therapy with NSAIDs, the patient should be observed closely for signs of renal failure, as well as to assure diuretic efficacy.

Glyburide

Etodolac has no apparent pharmacokinetic interaction when administered with glyburide.

Lithium

NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance. The mean minimum lithium concentration increased 15% and the renal clearance was decreased by approximately 20%. These effects have been attributed to inhibition of renal prostaglandin synthesis by the NSAID. Thus, when NSAIDs and lithium are administered concurrently, subjects should be observed carefully for signs of lithium toxicity.

Phenylbutazone

Phenylbutazone causes increase (by about 80%) in the free fraction of etodolac. Although in vivo studies have not been done to see if etodolac clearance is changed by coadministration of phenylbutazone, it is not recommended that they be coadministered.

Phenytoin

Etodolac has no apparent pharmacokinetic interaction when administered with phenytoin.

Warfarin

The effects of warfarin and NSAIDs on GI bleeding are synergistic, such that users of both drugs together have a risk of serious GI bleeding higher than that of users of either drug alone. Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and Lodine^Ò (etodolac capsules and tablets) results in reduced protein binding of warfarin, but there was no change in the clearance of free warfarin. There was no significant difference in the pharmacodynamic effect of warfarin administered alone and warfarin administered with Lodine as measured by prothrombin time. Thus, concomitant therapy with warfarin and Lodine should not require dosage adjustment of either drug. However, caution should be exercised because there have been a few spontaneous reports of prolonged prothrombin times, with or without bleeding, in etodolac-treated patients receiving concomitant warfarin therapy.

Drug/Laboratory Test Interactions

The urine of patients who take Lodine can give a false-positive reaction for urinary bilirubin (urobilin) due to the presence of phenolic metabolites of etodolac. Diagnostic dip-stick methodology, used to detect ketone bodies in urine, has resulted in false-positive findings in some patients treated with Lodine. Generally, this phenomenon has not been associated with other clinically significant events. No dose relationship has been observed.

Lodine treatment is associated with a small decrease in serum uric acid levels. In clinical trials, mean decreases of 1 to 2 mg/dL were observed in arthritic patients receiving etodolac (600 mg to 1000 mg/day) after 4 weeks of therapy. These levels then remained stable for up to 1 year of therapy.